| Strike Energy Limited (STX) ORDINARY FULLY PAID |
Energy |
$486 |
Strategic Placement to Fund Strike's Next Phase of Growth
|
22 Jul 2025 8:58AM |
$0.160 |
$0.135 |
fallen by
15.63%
|
|
STX - Price-sensitive ASX Announcement
Full Release
Key Points
- Strike Energy Limited announced a $60 million strategic placement.
- The placement will be made to institutional and sophisticated investors.
- Funds will be used to advance South Erregulla and other Perth Basin gas projects.
- Proceeds will also support appraisal, exploration, and general working capital.
- The placement aims to strengthen Strike’s balance sheet.
- This move aligns with Strike's strategy to accelerate growth and solidify its position in the Australian gas market.
- The announcement underscores Strike's commitment to domestic gas development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Carnarvon Energy Limited (CVN) ORDINARY FULLY PAID |
Energy |
$233 |
Strategic Investment in Strike Energy
|
22 Jul 2025 8:58AM |
$0.115 |
$0.130 |
risen by
13.04%
|
|
CVN - Price-sensitive ASX Announcement
Full Release
Key Points
- Carnarvon Energy Limited (CVN) announced a strategic investment in Strike Energy Limited.
- CVN acquired an 8.5% shareholding in Strike Energy.
- The investment aligns with CVN’s strategy to diversify its energy portfolio.
- Focus on exposure to low carbon energy opportunities.
- Synergies anticipated between Carnarvon and Strike Energy’s assets in Western Australia.
- The investment positions CVN to participate in future energy transition opportunities.
- CVN aims to strengthen its sustainability credentials and adapt to the evolving energy sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Strike Energy Limited (STX) ORDINARY FULLY PAID |
Energy |
$486 |
CVN: Strategic Investment in Strike Energy
|
22 Jul 2025 8:58AM |
$0.160 |
$0.135 |
fallen by
15.63%
|
|
| Carnarvon Energy Limited (CVN) ORDINARY FULLY PAID |
Energy |
$233 |
Strategic Investment by Carnarvon Energy
|
22 Jul 2025 8:58AM |
$0.115 |
$0.130 |
risen by
13.04%
|
|
| Strike Energy Limited (STX) ORDINARY FULLY PAID |
Energy |
$486 |
Strategic Investment by Carnarvon Energy
|
22 Jul 2025 8:58AM |
$0.160 |
$0.135 |
fallen by
15.63%
|
|
STX - Price-sensitive ASX Announcement
Full Release
Key Points
- Strike Energy Limited announced a strategic investment by Carnarvon Energy Limited.
- Carnarvon will acquire a 9.99% shareholding in Strike at $0.475 per share.
- The transaction will raise approximately $65 million for Strike Energy.
- The investment will support Strike’s ongoing and upcoming gas development projects, including the South Erregulla gas field.
- The collaboration is expected to create synergies by leveraging both companies' expertise and asset portfolios.
- Strike’s board and management welcome Carnarvon as a long-term, supportive shareholder.
- The placement is subject to customary conditions and is expected to complete shortly.
- The transaction strengthens Strike's balance sheet and positions it for future growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$49 |
Q4 FY25 Quarterly Investor Presentation & Webinar
|
22 Jul 2025 8:58AM |
$0.095 |
$0.080 |
fallen by
15.79%
|
|
MAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported progress on microbiome precision science and global partnerships.
- Highlighted expansion of therapeutic pipeline and initiation of clinical trials.
- Outlines new and expanded commercial agreements in microbiome testing.
- Describes collaborations with pharmaceutical companies to develop therapeutics.
- Summarizes financial performance, cash reserves, and revenue growth.
- Strategic priorities for FY26 include innovation, commercial execution, and leveraging proprietary technology.
- Focus on driving value through healthcare and research applications.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Riedel Resources Limited (RIE) ORDINARY FULLY PAID |
Materials |
$7 |
Share Purchase Plan Results
|
22 Jul 2025 8:57AM |
$0.037 |
$0.028 |
fallen by
24.32%
|
|
RIE - Price-sensitive ASX Announcement
Full Release
Key Points
- Riedel Resources Limited announced the results of its Share Purchase Plan (SPP).
- The SPP was well supported, with applications totaling about $1.71 million.
- This exceeded the targeted raising of $1.5 million.
- The Board decided to accept oversubscriptions above the original target.
- Funds will be used for exploration at the Kingman Gold Project in Arizona, USA, and for working capital.
- The company expressed gratitude to shareholders.
- A timeline for the issue and quotation of new shares was provided.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PMET Resources Inc (PMT) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$1,397 |
Patriot Battery Metals - July 2025 Webinar Presentation
|
22 Jul 2025 8:57AM |
$0.460 |
$0.760 |
risen by
65.22%
|
|
| Microba Life Sciences Limited (MAP) ORDINARY FULLY PAID |
Health Care |
$49 |
Q4 FY25 Quarterly Activities Report & Appendix 4C
|
22 Jul 2025 8:57AM |
$0.095 |
$0.080 |
fallen by
15.79%
|
|
MAP - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported several new clinical and commercial partnerships during the quarter.
- Announced advancement in the company’s therapeutic pipeline and diagnostic offerings.
- Strengthened collaborations with pharmaceutical and research organizations.
- Received grant funding and engaged in new research projects.
- Maintained a robust cash position with detailed disclosure of operational cash flows and expenditures.
- Outlined continued efforts to expand product adoption in the diagnostics market.
- Emphasized discipline in financial management and strategic investments.
- Provided Appendix 4C detailing quarterly cash flow and financial summary.
- Reiterated commitment to growth in microbial diagnostics and therapeutics.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Copper Search Limited (CUS) ORDINARY FULLY PAID |
Materials |
- |
Application for quotation of securities - CUS
|
22 Jul 2025 8:55AM |
$0.019 |
$0.018 |
fallen by
5.26%
|
|
| Boab Metals Limited (BML) ORDINARY FULLY PAID |
Materials |
$271 |
Corporate Presentation
|
22 Jul 2025 8:55AM |
$0.190 |
$0.470 |
risen by
147.37%
|
|
| Cogstate Limited (CGS) ORDINARY FULLY PAID |
Health Care |
$422 |
Cogstate FY2025 Results Webinar
|
22 Jul 2025 8:54AM |
$1.780 |
$2.470 |
risen by
38.76%
|
|
| Taiton Resources Limited (T88) ORDINARY FULLY PAID |
Materials |
$8 |
Ultrafine soil sampling at Challenger West And Highway
|
22 Jul 2025 8:53AM |
$0.060 |
$0.070 |
risen by
16.67%
|
|
T88 - Price-sensitive ASX Announcement
Full Release
Key Points
- Taiton Resources Limited completed an Ultrafine™ soil sampling program at Challenger West and Highway within the Lake Labyrinth Shear Zone.
- A total of 765 soil samples were collected and analyzed for multiple elements.
- New geochemical anomalies for gold, silver, copper, lead, and zinc were identified.
- Geochemical results correlate with structural trends interpreted from geophysical data.
- The results suggest potential mineralized systems and justify further exploration, including targeted drilling.
- The survey reinforces the exploration potential of the LLSZ as a mineralized corridor.
- The methodology, findings, and planned follow-up activities are detailed in the announcement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rokeby Resources Limited (RKB) ORDINARY FULLY PAID |
Materials |
$7 |
Drilling Underway at Hurricane
|
22 Jul 2025 8:51AM |
$0.012 |
$0.004 |
fallen by
66.67%
|
|
| Sunrise Energy Metals Limited (SRL) ORDINARY FULLY PAID |
Materials |
$2,056 |
June 2025 Quarterly Activities and Cash Flow
|
22 Jul 2025 8:51AM |
$1.250 |
$13.380 |
risen by
970.40%
|
|
SRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly activities focused on the advancement of the Sunrise Project.
- Updates provided on partnerships, funding, and stakeholder engagement.
- Details on exploration and development activities during the quarter.
- Financial statements and cash flow analyses included, covering operating, investing, and financing activities.
- Management commentary discusses the company’s ongoing strategy and future outlook.
- The report outlines risk factors and mitigation strategies relevant to SRL’s operations.
- Information on regulatory, environmental, and community engagement initiatives.
- Discussion of significant events and operational milestones achieved within the quarter.
- Future plans and objectives for the upcoming quarters are presented.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Core Energy Minerals Ltd (CR3) ORDINARY FULLY PAID |
Materials |
$7 |
Cummins Project Drilling Update
|
22 Jul 2025 8:49AM |
$0.011 |
$0.010 |
fallen by
9.09%
|
|
CR3 - Price-sensitive ASX Announcement
Full Release
Key Points
- Core Energy Minerals Ltd (CR3) provided a drilling update for the Cummins Project.
- Significant lithium mineralization was intersected, with high-grade spodumene observed.
- Drilling results confirmed thick, continuous pegmatite zones.
- Geological mapping and assays support the potential for a substantial lithium resource.
- The Cummins Project is a key asset in South Australia for lithium exploration.
- The company plans to continue drilling to further define and expand the resource.
- Core Energy Minerals aims to deliver a JORC-compliant resource estimate soon.
- The update reaffirms the strategic value of the Cummins Project in CR3's portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cogstate Limited (CGS) ORDINARY FULLY PAID |
Health Care |
$422 |
Change of Director's Interest Notice (Amended) - BOC
|
22 Jul 2025 8:48AM |
$1.780 |
$2.470 |
risen by
38.76%
|
|
| PPK Group Limited (PPK) ORDINARY FULLY PAID |
Materials |
$29 |
PPE launches new products that align with the CHB program
|
22 Jul 2025 8:46AM |
$0.435 |
$0.320 |
fallen by
26.44%
|
|
PPK - Price-sensitive ASX Announcement
Full Release
Key Points
- PPK Group Limited has launched new PPE products.
- The new products are designed to align with the CHB program.
- PPK emphasizes innovation and safety in its product development.
- The announcement provides details on the new PPE products and their uses.
- The company aims to address workplace safety and health with these offerings.
- The launch reflects PPK's strategic focus on advanced safety solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Praemium Limited (PPS) ORDINARY FULLY PAID |
Information Technology |
$341 |
Q4 FY2025 Update Presentation
|
22 Jul 2025 8:45AM |
$0.775 |
$0.700 |
fallen by
9.68%
|
|
PPS - Price-sensitive ASX Announcement
Full Release
Key Points
- Q4 FY2024 total Funds Under Administration (FUA) reached $55.6 billion, a significant year-on-year increase.
- Net inflows for the quarter were $1.2 billion, supporting continued growth momentum.
- Australian platform FUA increased by 18% over the last 12 months.
- International platform saw net inflows and improved engagement with advisers and clients.
- Ongoing investment in technology to enhance platform features and operational efficiency.
- Expansion of model portfolio offerings and managed account capabilities.
- Focus on adviser experience, including digital tools and client reporting enhancements.
- Continued progress on key strategic initiatives to drive sustainable growth.
- Positive outlook for FY2025, with further product innovation and market penetration planned.
- Praemium's net revenue and cost control measures have underpinned improved profit margins.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Falcon Metals Ltd (FAL) ORDINARY FULLY PAID |
Materials |
$108 |
Soil anomaly extended to 5.8km strike at Errabiddy
|
22 Jul 2025 8:44AM |
$0.710 |
$0.505 |
fallen by
28.87%
|
|
| West Coast Silver Limited (WCE) ORDINARY FULLY PAID |
Materials |
$63 |
FAL: Soil anomaly extended to 5.8km strike at Errabiddy
|
22 Jul 2025 8:44AM |
$0.150 |
$0.175 |
risen by
16.67%
|
|
| Solis Minerals Ltd (SLM) ORDINARY FULLY PAID |
Materials |
$26 |
More Visual Copper & Gold at Chancho al Palo, Peru
|
22 Jul 2025 8:44AM |
$0.081 |
$0.099 |
risen by
22.22%
|
|
SLM - Price-sensitive ASX Announcement
Full Release
Key Points
- Solis Minerals Ltd has announced visual copper and gold mineralization at the Chancho al Palo project in Peru.
- Multiple drill holes show extensive copper mineralization, confirming porphyry-style mineralization over significant intervals.
- The results support the potential for a substantial copper-gold resource at the project.
- Ongoing drilling is enhancing geological understanding and outlining the scale of the mineralized system.
- Further drilling and geophysical surveys are planned to define the resource and economic potential.
- The company’s exploration focus is on expanding and delineating mineralization zones at Chancho al Palo.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dorsavi Ltd (DVL) ORDINARY FULLY PAID |
Health Care |
$48 |
Breakthrough Results from RRAM Sensor Integration
|
22 Jul 2025 8:44AM |
$0.022 |
$0.040 |
risen by
81.82%
|
|
DVL - Price-sensitive ASX Announcement
Full Release
Key Points
- Dorsavi Ltd (DVL) announces breakthrough results from integrating RRAM sensors into their wearable technology.
- RRAM integration delivers improved sensitivity, miniaturization, and lower power consumption.
- The technology is aimed at clinical, sports, and occupational health markets.
- Enhanced data accuracy and real-time biomechanical monitoring are key benefits.
- Pilot trials and internal validation studies confirm technical and functional advantages.
- Dorsavi plans further development and commercialization of RRAM-enabled products.
- The company positions itself as an industry leader in wearable sensor innovation.
- The announcement details commercial opportunities arising from RRAM sensor technology.
- Next steps include expanding industry partnerships and securing regulatory approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Praemium Limited (PPS) ORDINARY FULLY PAID |
Information Technology |
$341 |
Q4 FY2025 Update
|
22 Jul 2025 8:43AM |
$0.775 |
$0.700 |
fallen by
9.68%
|
|
PPS - Price-sensitive ASX Announcement
Full Release
Key Points
- Praemium Limited released its Q4 FY2025 update with strong financial and operational results.
- Record quarterly net inflows were reported, reflecting increased adviser adoption and positive market conditions.
- Platform funds under administration (FUA) reached new highs, buoyed by growth in both the Australian and International businesses.
- The PPS platform saw enhancements in digital onboarding and adviser tools, supporting efficiency and client engagement.
- Initiatives in adviser education and engagement were emphasized as key drivers for the progress.
- The company continues to invest in technology while managing costs effectively.
- Strategic priorities for the upcoming year include expanding platform capabilities, improving client experience, and driving further net inflows.
- Outlook remains positive based on adviser demand, ongoing technology improvements, and a strong business pipeline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Genetic Signatures Limited (GSS) ORDINARY FULLY PAID |
Health Care |
$19 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
22 Jul 2025 8:43AM |
$0.420 |
$0.083 |
fallen by
80.24%
|
|
GSS - Price-sensitive ASX Announcement
Full Release
Key Points
- Genetic Signatures Limited (GSS) released its Quarterly Activities Report and Appendix 4C Cash Flow Report for the quarter ended 31 March 2024.
- Cash receipts during the quarter were $2.3 million, predominantly from product sales and government grants.
- Total cash outflows for the quarter were $4.2 million, with primary expenditures on product manufacturing, research and development, and staff costs.
- Net cash used in operating activities was $1.9 million, an improvement compared to the prior quarter.
- The company had a cash balance of $15.2 million at the end of the quarter.
- Key operational highlights include progress on clinical trials for the EasyScreen™ Gastrointestinal Parasite Detection Kit and regulatory submissions in the USA and Europe.
- Genetic Signatures continued its international expansion, focusing on increasing market share in Europe and the USA.
- Research and development efforts were ongoing to broaden the diagnostic product portfolio.
- No significant financing or investing activities were reported during the quarter.
- The company maintains sufficient funding to execute its planned commercial and R&D activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
